Clinical trials
Active, not recruiting Phase 2 Carcinoma, Ovarian Epithelial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CanariaBio Inc. | 1 |
| Instituto do Cancer do Estado de São Paulo | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Mercy Medical Center | 1 |
| SOLTI Breast Cancer Research Group | 1 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1 |
| University Health Network, Toronto | 1 |
| University of California, Davis | 1 |
| Wenjun Cheng | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 10 |
| Fallopian Tube Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Anus Neoplasms | 2 |
| Cholangiocarcinoma | 2 |
| Melanoma | 2 |
| Mesothelioma | 2 |
| Sarcoma | 2 |
| Thyroid Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.